Many people worry that carrying excess weight makes them less attractive to potential romantic partners, and both physicians and employers treat those with obesity differently. Furthermore, in psychiatry, many of the medications we prescribe lead to weight gain…, Obesity Treatment in Mental Illness: Is Semaglutide a Game Changer?  Dinah Miller, MD, 2021

It wasn’t until 2013 that the American Medical Association recognized obesity as a medical condition.

In a New Yorker article that same year, “Diet Drugs Work: Why Won’t Doctors Prescribe Them?” Suzanne Koven wrote, “…Several obesity experts told me they’ve encountered doctors who confide that they just didn’t like fat people and don’t enjoy taking care of them. Even doctors who treat obese patients feel stigmatized: ‘diet doctor’ is not a flattering term.”

Eat less, exercise more — with a blame-the-patient attitude — is still what people see as the “right” way to lose weight.

On June 4, 2021, the FDA approved semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, previously used for the treatment of diabetes, for use as a weight loss agent for patients with obesity, or for those with a body mass index over 27 if they also have a weight-related comorbidity.


You have Successfully Subscribed!